Precision Cell Systems, Inc.

Based in the US, Precision Cell Systems, Inc. specializes in advanced automated cell analysis solutions, offering innovative platforms that enhance biomedical research and clinical applications. Precision Cell Systems, Inc. focuses on developing automated solutions for cell analysis.

The company is headquartered in Livermore, US. Founded by experienced professionals in the biotechnology field, it has aimed to improve the efficiency of tissue dissociation and cell counting processes. There are no records of pivots or significant changes in business strategy since its inception. Precision Cell Systems specializes in advanced automated cell analysis solutions, primarily through its flagship products, the Singulator™ platform and the Moxi systems.

The Singulator™ automates the critical process of tissue dissociation, transforming fresh clinical biopsies into high viability single cell and nuclei suspensions with remarkable reproducibility. The Moxi systems leverage Coulter-based cell detection technology, utilizing innovative disposable cassette technology to deliver precise cell counts and sizing while minimizing maintenance disruptions associated with traditional flow cytometry. These products address significant challenges in single-cell analysis, particularly in research applications such as cancer immunotherapy and cellular therapy. The customer base includes research institutions, hospitals, and bioprocessing facilities globally, with a focus on markets in North America, Europe, and parts of Asia, where there is a growing demand for high-throughput cell analysis and isolation technologies.

Precision Cell Systems generates revenue through direct sales of its products, which include the Singulator™ and Moxi systems, to a diverse clientele engaged in biomedical research and clinical applications. The company employs a transactional structure that typically involves direct B2B sales to research laboratories and biopharmaceutical companies, facilitating seamless procurement of consumables, reagents, and specialized kits through their online store. Each product, notably the Moxi GO II™, is associated with pricing plans tailored to meet the specific needs of clients. The integration of software solutions compliant with regulatory requirements (such as 21 CFR Part 11) further enhances the value proposition for customers in regulated sectors, reinforcing Precision Cell Systems’ position as a preferred partner for organizations focused on advancing cell analysis technologies.